Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

I am a total failure: associations between beliefs and anxiety and depression in patients with inflammatory bowel disease with poor mental quality of life.

Bennebroek Evertsz' F, Sprangers MAG, de Vries LM, Sanderman R, Stokkers PCF, Verdam MGE, Burger H, Bockting CLH.

Behav Cogn Psychother. 2019 Aug 19:1-12. doi: 10.1017/S1352465819000444. [Epub ahead of print]

PMID:
31423955
2.

Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial.

de Groof EJ, Stevens TW, Eshuis EJ, Gardenbroek TJ, Bosmans JE, van Dongen JM, Mol B, Buskens CJ, Stokkers PCF, Hart A, D'Haens GR, Bemelman WA, Ponsioen CY; LIR!C study group.

Gut. 2019 Oct;68(10):1774-1780. doi: 10.1136/gutjnl-2018-317539. Epub 2019 Feb 1.

PMID:
31233395
3.

The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose.

Bosch S, Lemmen JP, Menezes R, van der Hulst R, Kuijvenhoven J, Stokkers PC, de Meij TG, de Boer NK.

J Breath Res. 2019 Jun 25;13(4):046001. doi: 10.1088/1752-7163/ab2775.

PMID:
31170704
4.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d'Haens G, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK; Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC).

BMJ Open. 2017 Nov 8;7(11):e016695. doi: 10.1136/bmjopen-2017-016695.

5.

Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial.

Bennebroek Evertsz' F, Sprangers MAG, Sitnikova K, Stokkers PCF, Ponsioen CY, Bartelsman JFWM, van Bodegraven AA, Fischer S, Depla ACTM, Mallant RC, Sanderman R, Burger H, Bockting CLH.

J Consult Clin Psychol. 2017 Sep;85(9):918-925. doi: 10.1037/ccp0000227.

PMID:
28857595
6.

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.

Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group.

Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Erratum in: Lancet Gastroenterol Hepatol. 2017 Nov;2(11):e7.

PMID:
28838644
7.

Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.

De Boer AG, Bennebroek Evertsz' F, Stokkers PC, Bockting CL, Sanderman R, Hommes DW, Sprangers MA, Frings-Dresen MH.

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1130-6. doi: 10.1097/MEG.0000000000000685.

PMID:
27340897
8.

Erratum to: The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019).

Gardenbroek TJ, Pinkney TD, Sahami S, Morton DG, Buskens CJ, Ponsioen CY, Tanis PJ, Löwenberg M, van den Brink GR, Broeders IA, Pullens HJ, Seerden T, Boom MJ, Mallant-Hent RC, Pierik RE, Vecht J, Sosef MN, van Nunen AB, van Wagensveld BA, Stokkers PC, Gerhards MF, Jansen JM, Acherman Y, Depla AC, Mannaerts GH, West R, Iqbal T, Pathmakanthan S, Howard R, Magill L, Singh B, Oo YH, Negpodiev D, Dijkgraaf MG, D'Haens GR, Bemelman WA.

BMC Surg. 2016 Jan 4;16:1. doi: 10.1186/s12893-015-0113-2. No abstract available.

9.

The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019).

Gardenbroek TJ, Pinkney TD, Sahami S, Morton DG, Buskens CJ, Ponsioen CY, Tanis PJ, Löwenberg M, van den Brink GR, Broeders IA, Pullens PH, Seerden T, Boom MJ, Mallant-Hent RC, Pierik RE, Vecht J, Sosef MN, van Nunen AB, van Wagensveld BA, Stokkers PC, Gerhards MF, Jansen JM, Acherman Y, Depla AC, Mannaerts GH, West R, Iqbal T, Pathmakanthan S, Howard R, Magill L, Singh B, Htun Oo Y, Negpodiev D, Dijkgraaf MG, Ram D'Haens G, Bemelman WA.

BMC Surg. 2015 Mar 18;15:30. doi: 10.1186/s12893-015-0017-1. Erratum in: BMC Surg. 2016;16:1. Pullens, Paul H J M [corrected to Pullens, Hendrikus J M]; Htun Oo, Ye [corrected to Oo, Ye H].

10.

Characterization and treatment of persistent hepatocellular secretory failure.

van Dijk R, Kremer AE, Smit W, van den Elzen B, van Gulik T, Gouma D, Lameris JS, Bikker H, Enemuo V, Stokkers PC, Feist M, Bosma P, Jansen PL, Beuers U.

Liver Int. 2015 Apr;35(4):1478-88. doi: 10.1111/liv.12603. Epub 2014 Jul 4.

PMID:
24905729
11.

ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn's disease patients.

Wolfkamp SC, Verseyden C, Vogels EW, Meisner S, Boonstra K, Peters CP, Stokkers PC, te Velde AA.

World J Gastroenterol. 2014 Mar 14;20(10):2664-72. doi: 10.3748/wjg.v20.i10.2664.

12.

Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients.

Peters CP, Eshuis EJ, Toxopeüs FM, Hellemons ME, Jansen JM, D'Haens GR, Fockens P, Stokkers PC, Tuynman HA, van Bodegraven AA, Ponsioen CY; North Holland GUT club.

J Crohns Colitis. 2014 Aug;8(8):866-75. doi: 10.1016/j.crohns.2014.01.012. Epub 2014 Jan 31.

PMID:
24491515
13.

Exogenous pigment in Peyer patches of children suspected of having IBD.

Hummel TZ, Kindermann A, Stokkers PC, Benninga MA, ten Kate FJ.

J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):477-80. doi: 10.1097/MPG.0000000000000221.

PMID:
24164906
14.

Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.

van Bodegraven AA, Bravenboer N, Witte BI, Dijkstra G, van der Woude CJ, Stokkers PC, Russel MG, Oldenburg B, Pierik M, Roos JC, van Hogezand RA, Dik VK, Oostlander AE, Netelenbos JC, van de Langerijt L, Hommes DW, Lips P; Dutch Initiative on Crohn and Colitis (ICC).

Gut. 2014 Sep;63(9):1424-30. doi: 10.1136/gutjnl-2013-305523. Epub 2013 Oct 21.

PMID:
24146170
15.

Reply to Drs. Walmsley and Casey letter.

Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA.

J Crohns Colitis. 2013 Dec;7(11):932. doi: 10.1016/j.crohns.2013.06.016. Epub 2013 Aug 7. No abstract available.

PMID:
23932784
16.

Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity.

Bennebroek Evertsz' F, Hoeks CC, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA.

J Clin Gastroenterol. 2013 Nov-Dec;47(10):850-6. doi: 10.1097/MCG.0b013e31828b2196.

PMID:
23632348
17.

Ten years of infliximab for Crohn's disease: outcome in 469 patients from 2 tertiary referral centers.

Eshuis EJ, Peters CP, van Bodegraven AA, Bartelsman JF, Bemelman W, Fockens P, D'Haens GR, Stokkers PC, Ponsioen CY.

Inflamm Bowel Dis. 2013 Jul;19(8):1622-30. doi: 10.1097/MIB.0b013e318281f4c4.

PMID:
23552767
18.

Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study.

Ziech ML, Lavini C, Bipat S, Ponsioen CY, Spijkerboer AM, Stokkers PC, Nederveen AJ, Stoker J.

AJR Am J Roentgenol. 2013 Feb;200(2):W170-7. doi: 10.2214/AJR.11.8276.

PMID:
23345381
19.

Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia.

van Schaik FD, Mooiweer E, van der Have M, Belderbos TD, Ten Kate FJ, Offerhaus GJ, Schipper ME, Dijkstra G, Pierik M, Stokkers PC, Ponsioen C, de Jong DJ, Hommes DW, van Bodegraven AA, Siersema PD, van Oijen MG, Oldenburg B; Dutch Initiative on Crohn Colitis.

Inflamm Bowel Dis. 2013 Feb;19(2):342-9. doi: 10.1097/MIB.0b013e318286f771.

PMID:
23340679
20.

The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.

Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA.

J Crohns Colitis. 2013 Dec;7(11):890-900. doi: 10.1016/j.crohns.2012.11.007. Epub 2012 Dec 24.

PMID:
23269224
21.

The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study).

Bennebroek Evertsz' F, Bockting CL, Stokkers PC, Hinnen C, Sanderman R, Sprangers MA.

BMC Psychiatry. 2012 Dec 14;12:227. doi: 10.1186/1471-244X-12-227.

22.

Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease.

Ziech ML, Lavini C, Caan MW, Nio CY, Stokkers PC, Bipat S, Ponsioen CY, Nederveen AJ, Stoker J.

Eur J Radiol. 2012 Nov;81(11):3019-27. doi: 10.1016/j.ejrad.2012.03.028. Epub 2012 Jun 30.

23.

Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.

Wolfkamp SC, Verstege MI, Vogels EW, Meisner S, Verseijden C, Stokkers PC, te Velde AA.

Eur J Gastroenterol Hepatol. 2012 Aug;24(8):965-70. doi: 10.1097/MEG.0b013e328354f3d5.

PMID:
22664939
24.

Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis.

Eshuis EJ, Al Saady RL, Stokkers PC, Ponsioen CY, Tanis PJ, Bemelman WA.

J Crohns Colitis. 2013 Mar;7(2):142-9. doi: 10.1016/j.crohns.2012.03.013. Epub 2012 Apr 26.

PMID:
22542056
25.

Maternal imprinting and female predominance in familial Crohn's disease.

Zelinkova Z, Stokkers PC, van der Linde K, Kuipers EJ, Peppelenbosch MP, van der Woude CP.

J Crohns Colitis. 2012 Aug;6(7):771-6. doi: 10.1016/j.crohns.2012.01.002. Epub 2012 Jan 23.

PMID:
22398090
26.

Do Inflammatory Bowel Disease patients with anxiety and depressive symptoms receive the care they need?

Bennebroek Evertsz' F, Thijssens NA, Stokkers PC, Grootenhuis MA, Bockting CL, Nieuwkerk PT, Sprangers MA.

J Crohns Colitis. 2012 Feb;6(1):68-76. doi: 10.1016/j.crohns.2011.07.006. Epub 2011 Sep 9.

PMID:
22261530
27.

Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.

Hommes DW, Duijvestein M, Zelinkova Z, Stokkers PC, Ley MH, Stoker J, Voermans C, van Oers MH, Kersten MJ.

J Crohns Colitis. 2011 Dec;5(6):543-9. doi: 10.1016/j.crohns.2011.05.004. Epub 2011 Jun 12.

PMID:
22115372
28.

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

Nijmeijer RM, Gadaleta RM, van Mil SW, van Bodegraven AA, Crusius JB, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC, Verspaget HW, Weersma RK, van der Woude CJ, Stapelbroek JM, Schipper ME, Wijmenga C, van Erpecum KJ, Oldenburg B; Dutch Initiative on Crohn, Colitis (ICC).

PLoS One. 2011;6(8):e23745. doi: 10.1371/journal.pone.0023745. Epub 2011 Aug 22.

29.

Anti tumour necrosis factor as risk factor for free perforations in Crohn's disease? A case-control study.

Eshuis EJ, Griffioen GH, Stokkers PC, Ubbink DT, Bemelman WA.

Colorectal Dis. 2012 May;14(5):578-84. doi: 10.1111/j.1463-1318.2011.02764.x.

PMID:
21848898
30.

[Ileus as a manifestation of intestinal tuberculosis].

Hoentjen F, Stokkers PC, Veenstra J.

Ned Tijdschr Geneeskd. 2011;155(32):A3344. Dutch.

PMID:
21835062
31.

Rectification of miscalculation of adalimumab costs.

Eshuis EJ, Stokkers PC, Bemelman WA.

Expert Rev Gastroenterol Hepatol. 2011 Aug;5(4):437-8. doi: 10.1586/egh.11.15. No abstract available.

PMID:
21780889
32.

Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences.

van den Broek FJ, Stokkers PC, Reitsma JB, Boltjes RP, Ponsioen CY, Fockens P, Dekker E.

Am J Gastroenterol. 2014 May;109(5):715-22. doi: 10.1038/ajg.2011.93. Epub 2011 Mar 22.

PMID:
21427710
33.

Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands.

Baars JE, Kuipers EJ, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC, Oldenburg B, Pierik M, Wahab PJ, van Bodegraven AA, van der Woude CJ; Initiative for Crohn and Colitis.

Scand J Gastroenterol. 2011 Mar;46(3):319-25. doi: 10.3109/00365521.2010.536251.

PMID:
21299339
34.

A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease.

Festen EA, Goyette P, Green T, Boucher G, Beauchamp C, Trynka G, Dubois PC, Lagacé C, Stokkers PC, Hommes DW, Barisani D, Palmieri O, Annese V, van Heel DA, Weersma RK, Daly MJ, Wijmenga C, Rioux JD.

PLoS Genet. 2011 Jan 27;7(1):e1001283. doi: 10.1371/journal.pgen.1001283.

35.

Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis.

van den Broek FJ, Fockens P, van Eeden S, Stokkers PC, Ponsioen CY, Reitsma JB, Dekker E.

Endoscopy. 2011 Feb;43(2):108-15. doi: 10.1055/s-0030-1255956. Epub 2010 Dec 16.

PMID:
21165822
36.

Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis.

van den Broek FJ, van Es JA, van Eeden S, Stokkers PC, Ponsioen CY, Reitsma JB, Fockens P, Dekker E.

Endoscopy. 2011 Feb;43(2):116-22. doi: 10.1055/s-0030-1255954. Epub 2010 Dec 16.

PMID:
21165821
37.

Suicide attempt in ulcerative colitis patient after 4 months of infliximab therapy--a case report.

Eshuis EJ, Magnin KM, Stokkers PC, Bemelman WA, Bartelsman J.

J Crohns Colitis. 2010 Nov;4(5):591-3. doi: 10.1016/j.crohns.2010.04.001. Epub 2010 Jun 16.

PMID:
21122565
38.

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M.

Nat Genet. 2010 Dec;42(12):1118-25. doi: 10.1038/ng.717.

39.

Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease.

Oostlander AE, Bravenboer N, Sohl E, Holzmann PJ, van der Woude CJ, Dijkstra G, Stokkers PC, Oldenburg B, Netelenbos JC, Hommes DW, van Bodegraven AA, Lips P; Dutch Initiative on Crohn and Colitis (ICC).

Gastroenterology. 2011 Jan;140(1):116-23. doi: 10.1053/j.gastro.2010.09.007. Epub 2010 Sep 18.

PMID:
20854819
40.

Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations.

Weersma RK, Crusius JB, Roberts RL, Koeleman BP, Palomino-Morales R, Wolfkamp S, Hollis-Moffatt JE, Festen EA, Meisneris S, Heijmans R, Noble CL, Gearry RB, Barclay ML, Gómez-Garcia M, Lopez-Nevot MA, Nieto A, Rodrigo L, Radstake TR, van Bodegraven AA, Wijmenga C, Merriman TR, Stokkers PC, Peña AS, Martín J, Alizadeh BZ.

Inflamm Bowel Dis. 2010 Dec;16(12):2080-9. doi: 10.1002/ibd.21342.

PMID:
20848524
41.

Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.

van Schaik FD, ten Kate FJ, Offerhaus GJ, Schipper ME, Vleggaar FP, van der Woude CJ, Stokkers PC, de Jong DJ, Hommes DW, van Bodegraven AA, Siersema PD, Oldenburg B; Dutch Initiative on Crohn and Colitis.

Inflamm Bowel Dis. 2011 May;17(5):1108-16. doi: 10.1002/ibd.21467. Epub 2010 Sep 7.

PMID:
20824815
42.

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismüller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH; IBSEN Study Group, Stokkers PC, Vermeire S, Mathew CG, Lie BA, Beuers U, Manns MP, Schreiber S, Schrumpf E, Häussinger D, Franke A, Karlsen TH.

PLoS One. 2010 Aug 25;5(8):e12403. doi: 10.1371/journal.pone.0012403.

43.

Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease.

Fransen K, Visschedijk MC, van Sommeren S, Fu JY, Franke L, Festen EA, Stokkers PC, van Bodegraven AA, Crusius JB, Hommes DW, Zanen P, de Jong DJ, Wijmenga C, van Diemen CC, Weersma RK.

Hum Mol Genet. 2010 Sep 1;19(17):3482-8. doi: 10.1093/hmg/ddq264. Epub 2010 Jul 3.

PMID:
20601676
44.

Is there a role for Crohn's disease-associated autophagy genes ATG16L1 and IRGM in formation of granulomas?

Wolfkamp SC, Te Velde AA, Weersma RK, Ponsioen CY, Stokkers PC.

Eur J Gastroenterol Hepatol. 2010 Aug;22(8):933-7. doi: 10.1097/MEG.0b013e32833775e6.

PMID:
20395867
45.

Decision-making in ileocecal Crohn's disease management: surgery versus pharmacotherapy.

Eshuis EJ, Stokkers PC, Bemelman WA.

Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):181-9. doi: 10.1586/egh.10.3. Review.

PMID:
20350265
46.

Genome-wide association identifies multiple ulcerative colitis susceptibility loci.

McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D'Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard EJ, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK; NIDDK IBD Genetics Consortium, Sharma Y, Silverberg MS, Cho JH, Wu J, Roeder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seielstad M.

Nat Genet. 2010 Apr;42(4):332-7. doi: 10.1038/ng.549. Epub 2010 Mar 14. Erratum in: Nat Genet. 2011 Apr;43(4):388.

47.

Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn's disease.

Eshuis EJ, Slors JF, Stokkers PC, Sprangers MA, Ubbink DT, Cuesta MA, Pierik EG, Bemelman WA.

Br J Surg. 2010 Apr;97(4):563-8. doi: 10.1002/bjs.6918.

PMID:
20175126
48.

Laparoscopic resection with transcolonic specimen extraction for ileocaecal Crohn's disease.

Eshuis EJ, Voermans RP, Stokkers PC, van Berge Henegouwen MI, Fockens P, Bemelman WA.

Br J Surg. 2010 Apr;97(4):569-74. doi: 10.1002/bjs.6932.

PMID:
20155789
49.

Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.

Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude CJ, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK.

Am J Gastroenterol. 2010 Feb;105(2):395-402. doi: 10.1038/ajg.2009.576. Epub 2009 Oct 27. Erratum in: Am J Gastroenterol. 2010 Feb;105(2):479. van der Woude, Janneke C [corrected to van der Woude, C Janneke].

PMID:
19861958
50.

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

Lutgens MW, Oldenburg B, Siersema PD, van Bodegraven AA, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC, van der Woude CJ, Vleggaar FP.

Br J Cancer. 2009 Nov 17;101(10):1671-5. doi: 10.1038/sj.bjc.6605359. Epub 2009 Oct 13.

Supplemental Content

Loading ...
Support Center